Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene
Hidenori Toyoda, Takashi Kumada, Kazuhiko Hayashi, Takashi Honda, Yoshiaki Katano, Hidemi Goto, Takahisa Kawaguchi, Yoshiki Murakami, Fumihiko MatsudaVolume:
83
Year:
2011
Language:
english
Pages:
6
DOI:
10.1002/jmv.22145
File:
PDF, 92 KB
english, 2011